Reaction
Sputum Abnormal reporting signals
As of the last recalculation, Sputum Abnormal appears in 645 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is AMIKACIN (PRR 43.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amikacin | 22 | 43.1 | 43.1 |
| Theophylline Anhydrous | 13 | 34.5 | 34.5 |
| Theophylline | 12 | 34.3 | 34.3 |
| Tobramycin | 24 | 33.4 | 33.4 |
| Mepolizumab | 47 | 32.8 | 32.9 |
| Cefepime Hydrochloride | 11 | 22.4 | 22.4 |
| Tobramycin Solution | 8 | 21.7 | 21.8 |
| Tobramycin Sulfate | 8 | 21.1 | 21.1 |
| Dornase Alfa | 12 | 20.1 | 20.1 |
| Canakinumab | 6 | 18.1 | 18.1 |
| Aprepitant | 10 | 17.7 | 17.7 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 6 | 15.7 | 15.7 |
| Pirfenidone | 7 | 5.6 | 5.6 |